Case Studies
123...4
Feb 8th, 2023
CSD in Action: Augmented Reality Visualization Brings Zr-Oxide MOFs for Gas Adsorption to Life Following Computational Characterization
Aug 15th, 2022
CSD in action: advancing Metal Organic Frameworks (MOFs) using Big Data and High Throughput Screening
Jul 26th, 2022
CSD in action: contributions of molecular design in drug discovery at Roche
Jun 20th, 2022
CSD in action: Merck & Co. Inc. Predicting the formation of drug solvent adducts by computational crystal structure prediction
May 24th, 2022
CSD in action: training a machine learning model to predict MOF pore accessibility with 80% certainty
May 11th, 2022
CSD in action: Novartis. CSD-validated data helps discover compounds with 50% increase in potency for treatment of SMA
Jan 26th, 2022
CSD-Materials in Action: Molecular Complementarity component reduces required benchtop experiments by 24%
Dec 15th, 2021
GOLD in action: leveraging structure-based drug design methods to develop novel herbicides
123...4